Figure 2.
Patient disposition. *Five patients in the placebo group who were PASI 75 responders at Week 12 did not proceed into the maintenance period as defined in the protocol. HD, high dose; LD, low dose; SEC, secukinumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.